Arkema recently announced the proposed divestment of its epoxides business to Cargill. With this project, Arkema reports that it is pursuing the repositioning of its portfolio on its core businesses.
Arkema produces bio-based and specialty epoxides in Blooming Prairie, Minn. These epoxides are used as additives or intermediates in the manufacture of lubricants, plastic additives, and a variety of other applications. Part of Arkema’s Hydrogen Peroxide activity, this business has limited integration with the rest of the group’s portfolio, generates sales of around $40 million, and employs approximately 45 people.
The received offer reportedly values this activity at $38.8 million, which is around 10 times historical EBITDA. The deal is expected to close in the fourth quarter of 2021.